Navigation Links
Adam Chasse Inducted Into Delta Omega Public Health Honorary Society
Date:4/24/2012

ELLICOTT CITY, Md., April 24, 2012 /PRNewswire/ -- Adam Chasse, RxTrials' vice president of Corporate Development, was inducted into Delta Omega, the public health honorary society, during ceremonies at the University of North Carolina at Chapel Hill (UNC-CH), on Friday, April 20.

Chasse earned a Master of Healthcare Administration degree in 2011 from the Gillings School of Global Public Health at UNC-CH. He has a long and distinguished career in clinical research, having served in various roles at international CRO Quintiles from 1995 until joining RxTrials last year. At RxTrials, he directs the organization's growth by increasing study volume and enhancing strategic relationships. Throughout his career, Chasse has been committed to improving quality and operational efficiency in clinical research in order to help new medicines get into the hands of the patients that need them.

The Delta Omega Honorary Society in Public Health was founded in 1924 to recognize outstanding achievement in the field of public health. As the scope of public health has broadened, Delta Omega expanded its reach while still recognizing its founding ideals. Today's members come from a broad spectrum of professions dedicated to public health.

"Inasmuch as membership in Delta Omega recognizes dedication to quality and advancement of good health for all, this is a proud personal achievement for me," Chasse said, "but just as importantly, those are the values my RxTrials colleagues and I strive to demonstrate for our patients and our clients every day.  This honor reinforces that commitment."

RxTrials, Inc., is a network of premier clinical research sites that, through partnerships with more than 100 top study sponsors and CROs, has conducted more than 1,000 studies helping to bring new drugs, vaccines and medical devices to market. It also is the parent company of RxTrials Institute, a leading national clinical research consultant and education provider. RxTrials Institute each year presents the Site Solutions Summit, a top networking and business management conference for clinical research sites, sponsors and CROs.


'/>"/>
SOURCE RxTrials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. RxTrials Announces Hiring Adam Chasse as VP of Business Development
2. Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
3. Wyle Engineer Inducted Into Space Technology Hall of Fame for Work on Growing Human Cells in Space
4. MiMedx Groups Chairman, Parker H. "Pete" Petit, Is Inducted Into the National Academy of Engineering
5. Applied Precision Installs New DeltaVision
6. OMX® Super-Resolution Imaging System in the Light Microscopy Imaging Center at Indiana University
7. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
8. Ed Weimer Joins Delta Point, Inc. as Executive Account Director
9. Applied Precision Announces the 25th Installation of Its DeltaVision OMX Super-Resolution Microscope at McGill University
10. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
11. OmegaGenesis Announces Angiogenesis Application Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):